Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
http://link.springer.com/content/pdf/10.1186/s40560-014-0051-6.pdf
Reference63 articles.
1. Hunt BJ: Bleeding and coagulopathies in critical care. N Engl J Med 2014, 370: 847-859. 10.1056/NEJMra1208626
2. Levi M, van der Poll T: Inflammation and coagulation. Crit Care Med 2010,38(Suppl):S26-S34. 10.1097/CCM.0b013e3181c98d21
3. Iba T, Gando S, Thachil J: Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan. J Thromb Haemost 2014, 12: 1010-1019. 10.1111/jth.12596
4. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012, 366: 2055-2064. 10.1056/NEJMoa1202290
5. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Pénzes I, Kübler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286: 1869-1878. 10.1001/jama.286.15.1869
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Suppression of overactivated immunity in the early stage is the key to improve the prognosis in severe burns;Frontiers in Immunology;2024-09-06
2. Diagnostic and therapeutic value of human serpin family proteins;Biomedicine & Pharmacotherapy;2024-06
3. Administration of antithrombin for septic DIC;Japanese Journal of Thrombosis and Hemostasis;2024
4. Effects of combination therapy of antithrombin and thrombomodulin;Japanese Journal of Thrombosis and Hemostasis;2024
5. Heteropolysaccharides in sustainable corrosion inhibition: 4E (Energy, Economy, Ecology, and Effectivity) dimensions;International Journal of Biological Macromolecules;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3